NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $625,974 | +10.8% | 86,464 | +14.3% | 0.00% | 0.0% |
| Q2 2023 | $564,727 | +27.2% | 75,631 | +18.5% | 0.00% | 0.0% |
| Q1 2023 | $443,852 | -22.9% | 63,809 | +13.9% | 0.00% | 0.0% |
| Q4 2022 | $575,717 | -34.4% | 56,039 | +16.0% | 0.00% | -50.0% |
| Q3 2022 | $878,000 | -67.9% | 48,292 | -8.8% | 0.00% | -66.7% |
| Q2 2022 | $2,733,000 | -46.2% | 52,968 | -25.0% | 0.01% | -40.0% |
| Q1 2022 | $5,082,000 | -52.5% | 70,631 | -5.5% | 0.01% | -50.0% |
| Q4 2021 | $10,693,000 | +5.2% | 74,740 | +51.7% | 0.02% | -4.8% |
| Q3 2021 | $10,169,000 | +4.8% | 49,269 | +7.8% | 0.02% | 0.0% |
| Q2 2021 | $9,704,000 | +12.4% | 45,683 | -3.9% | 0.02% | 0.0% |
| Q1 2021 | $8,630,000 | +48.2% | 47,559 | -8.9% | 0.02% | +31.2% |
| Q4 2020 | $5,822,000 | +66.9% | 52,202 | +59.4% | 0.02% | +60.0% |
| Q3 2020 | $3,488,000 | +28.1% | 32,758 | +0.3% | 0.01% | +11.1% |
| Q2 2020 | $2,722,000 | +296.2% | 32,670 | -34.8% | 0.01% | +200.0% |
| Q1 2020 | $687,000 | – | 50,124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |